| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia
|
King, Amber C.
|
|
2019
|
79 |
C |
p. 27-33
|
artikel
|
| 2 |
Chronic myeloid leukemia: Two mysteries
|
Radivoyevitch, Tomas
|
|
2019
|
79 |
C |
p. 3-5
|
artikel
|
| 3 |
Editorial Board
|
|
|
2019
|
79 |
C |
p. ii
|
artikel
|
| 4 |
Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation
|
Jaramillo, Adrian C.
|
|
2019
|
79 |
C |
p. 45-51
|
artikel
|
| 5 |
Flow cytometry diagnosis in myelodysplastic syndrome: Current practice in Latin America and comparison with other regions of the world
|
Grille, S.
|
|
2019
|
79 |
C |
p. 69-74
|
artikel
|
| 6 |
Improving risk-stratification of patients with chronic lymphocytic leukemia using multivariate patient similarity networks
|
Turcsanyi, Peter
|
|
2019
|
79 |
C |
p. 60-68
|
artikel
|
| 7 |
Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease
|
Lemieux, Christopher
|
|
2019
|
79 |
C |
p. 75-80
|
artikel
|
| 8 |
Pak1 gene functioned differentially in different BCR-ABL subtypes in leukemiagenesis and treatment response through STAT5 pathway
|
Yuanxin, Ye
|
|
2019
|
79 |
C |
p. 6-16
|
artikel
|
| 9 |
Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib
|
Gerds, Aaron T.
|
|
2019
|
79 |
C |
p. 38-44
|
artikel
|
| 10 |
Programmed Cell Death Receptor (PD-1) Ligand (PD-L1) expression in Philadelphia chromosome-negative myeloproliferative neoplasms
|
Wang, Jen-Chin
|
|
2019
|
79 |
C |
p. 52-59
|
artikel
|
| 11 |
Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab
|
Špaček, Martin
|
|
2019
|
79 |
C |
p. 17-21
|
artikel
|
| 12 |
Replicative senescence of hematopoietic cells in patients with idiopathic cytopenia of undetermined significance
|
Shin, Dong-Yeop
|
|
2019
|
79 |
C |
p. 22-26
|
artikel
|
| 13 |
The spectrum of musculoskeletal symptoms in patients with chronic myeloid leukemia after stopping tyrosine kinase inhibitors
|
Diab, Maria
|
|
2019
|
79 |
C |
p. 1-2
|
artikel
|
| 14 |
The value of FDP/FIB and D-dimer/FIB ratios in predicting high-risk APL-related thrombosis
|
Bai, Yanliang
|
|
2019
|
79 |
C |
p. 34-37
|
artikel
|
Tijdschrift beschrijving